Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes to greenhouse gas emissions and poses a threat to the environment.<\/p>\n
The partnership involves the deployment of Blue-Zone’s patented anaesthetic gas recycling technology, which captures and recycles waste anaesthetic gases, thereby reducing the amount of these potent greenhouse gases released into the atmosphere. This technology has the potential to significantly decrease the carbon footprint of healthcare facilities and contribute to a more sustainable future.<\/p>\n
Under the terms of the agreement, Piramal Critical Care will work closely with Blue-Zone to promote and implement the anaesthetic gas recycling technology in healthcare facilities across the United States and Europe. The company will leverage its extensive network and expertise in the field of inhalation anaesthetics to raise awareness about the importance of anaesthetic gas recycling and the benefits of this innovative technology.<\/p>\n
The recycling process involves the use of a specialized device that captures the waste anaesthetic gases and recycles them, resulting in a significant reduction in greenhouse gas emissions. This technology has been shown to be highly effective, with the ability to capture up to 90% of waste anaesthetic gases. By reducing the amount of these gases released into the atmosphere, healthcare facilities can significantly decrease their environmental impact and contribute to a more sustainable future.<\/p>\n
The partnership between Piramal Critical Care and Blue-Zone Technologies is a significant step towards reducing the environmental impact of anaesthetic gas waste. The collaboration demonstrates the commitment of both companies to sustainability and their dedication to providing innovative solutions that prioritize the well-being of both patients and the environment. As the healthcare industry continues to evolve, partnerships like this one will play a crucial role in shaping a more sustainable future for generations to come. With the potential to significantly reduce greenhouse gas emissions, this initiative has the potential to make a substantial impact on the environment and public health.<\/p>\n","protected":false},"excerpt":{"rendered":"
Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes to greenhouse gas emissions and […]<\/p>\n","protected":false},"author":1,"featured_media":88139,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2,27],"tags":[],"class_list":["post-89907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma","category-piramal-pharma"],"jetpack_featured_media_url":"https:\/\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89792,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","url_meta":{"origin":89907,"position":0},"title":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company's sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89660,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/13\/does-piramal-pharma-limited-possess-sustainable-competitive-advantages-for-sustained-long-term-expansion-analyzing-earnings-trends-capitalizing-on-exceptional-growth-opportunities\/","url_meta":{"origin":89907,"position":1},"title":"Does Piramal Pharma Limited Possess Sustainable Competitive Advantages for Sustained Long-Term Expansion – Analyzing Earnings Trends & Capitalizing on Exceptional Growth Opportunities","author":"Team Small News","date":"December 13, 2025","format":false,"excerpt":"Piramal Pharma Limited, a leading pharmaceutical company, has been exhibiting remarkable growth patterns, making it an attractive investment opportunity. To determine if the company has competitive moats for long-term growth, it's essential to analyze its earnings growth patterns and market trends. Piramal Pharma has demonstrated a strong track record of\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89777,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/10\/jefferies-names-sai-life-and-divis-labs-as-top-choices-in-the-contract-research-and-development-manufacturing-organization-crdmo-sector-while-reducing-target-prices-for-piramal-pharma-and-cohance\/","url_meta":{"origin":89907,"position":2},"title":"Jefferies names Sai Life and Divi’s Labs as top choices in the contract research and development manufacturing organization (CRDMO) sector, while reducing target prices for Piramal Pharma and Cohance.","author":"Team Small News","date":"January 10, 2026","format":false,"excerpt":"Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. Sai Life Sciences and Divi's Labs have emerged as Jefferies' top picks in the\u2026","rel":"","context":"In "Divi's Laboratories"","block_context":{"text":"Divi's Laboratories","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/divis-laboratories\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89667,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/14\/us-biosecure-act-sparks-china1-opportunity-for-indian-contract-development-and-manufacturing-organizations-cdmos-with-piramal-pharma-anticipating-significant-long-term-benefits\/","url_meta":{"origin":89907,"position":3},"title":"US Biosecure Act sparks China+1 opportunity for Indian contract development and manufacturing organizations (CDMOs), with Piramal Pharma anticipating significant long-term benefits.","author":"Team Small News","date":"December 14, 2025","format":false,"excerpt":"The proposed US Biosecure Act, which aims to restrict certain biotech and pharmaceutical contracts involving China, could open up a significant opportunity for Indian contract development and manufacturing organizations (CDMOs) over the next few years. According to Nandini Piramal, Chairperson of Piramal Pharma, the Act could contribute to the broader\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89888,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/02\/01\/hosmac-has-designed-ciplas-breathefree-lung-wellness-centre-in-mumbai-focusing-on-adaptive-reuse-and-a-wellness-centric-approach-as-reported-by-prop-news-time\/","url_meta":{"origin":89907,"position":4},"title":"HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.","author":"Team Small News","date":"February 1, 2026","format":false,"excerpt":"HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness. The design of the centre emphasizes adaptive reuse, transforming an existing building into a\u2026","rel":"","context":"In "Cipla"","block_context":{"text":"Cipla","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/cipla\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89820,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/18\/mankind-pharma-launches-cutting-edge-digital-classrooms-bolstering-community-centric-education-through-kindcare-initiative-as-reported-by-india-education-diary\/","url_meta":{"origin":89907,"position":5},"title":"Mankind Pharma launches cutting-edge digital classrooms, bolstering community-centric education through KindCare initiative, as reported by India Education Diary.","author":"Team Small News","date":"January 18, 2026","format":false,"excerpt":"Mankind Pharma, a leading pharmaceutical company, has launched digital smart classrooms as part of its KindCare initiative, aiming to revolutionize community-first education in India. The inauguration of these state-of-the-art classrooms marks a significant milestone in the company's efforts to bridge the educational gap and provide quality learning opportunities to underprivileged\u2026","rel":"","context":"In "Mankind"","block_context":{"text":"Mankind","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/mankind\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89907"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media\/88139"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}